Jb. Grammer et al., IMPREGNATION OF COLLAGEN CORNEAL SHIELDS WITH LIPOSOMES - UPTAKE AND RELEASE OF HYDROPHILIC AND LIPOPHILIC MARKER SUBSTANCES, Current eye research, 15(8), 1996, pp. 815-823
Purpose. Liposomes and collagen corneal shields (CCS) have been used a
s ophthalmic drug delivery devices. With regard to a possibly combined
application, we studied the effects of surface charge and bilayer flu
idity of liposomes on their uptake and release by CCS. Methods. 12-hou
rs-CCS were soaked in large unilamellar liposomes, which had been labe
lled with 4,5-carboxyfluorescein (CF) and N-(lissamine rhodamine B sul
fonyl)-diacylphosphatidylethanolamine (PE-RhB) in the aqueous space an
d in the liposome bilayer, respectively. Released fluorophores were de
termined fluorometrically in the elution buffer at intervals from 1 to
240 min after immersion.Results. The CF concentration in the CCS soak
ed in a CF solution was two to seven times higher than immersion in th
e liposome suspensions. Among those, the negatively charged, cholester
ol-containing preparation led to the highest CF concentration in the C
CS. The PE-RhB concentration was highest after soaking the CCS in neut
ral, cholesterol-free liposomes. All types of liposomes were found ins
ide the CCS by freeze fracture electron microscopy. The release kineti
cs data indicate a first order release. More than 90% of CF was releas
ed by the CCS within the first 30 min. This was equal after soaking th
e CCS in the CF solution or in liposomes. With DOPC-liposomes, the max
imal release was already attained after 10 min. In general, the differ
ences in the release kinetics of both hydrophilic and lipophilic marke
rs, obtained by the various liposome types were small. Conclusions. Ou
r results indicate that surface charge and bilayer fluidity are of min
or importance for the interaction with collagen corneal shields. Howev
er, since the release kinetics of a liposome-encapsulated hydrophilic
or lipophilic substance are similar to the release of a non-encapsulat
ed drug, the combination of liposomes with collagen shields may be use
ful mainly with respect to the encapsulation of drugs which do not pen
etrate the ocular surface as well as to prolong corneal contact time o
f the liposomes.